Parexel International competitors

Zippia Score 4.5

Parexel International main competitors are Cytel, Vertex Pharmaceuticals, and ExecuPharm.

Competitor Summary. See how Parexel International compares to its main competitors:

Pfizer has the most employees (78,500).
Employees at Cytel earn more than most of the competitors, with an average yearly salary of $104,401.
The oldest company is Pfizer, founded in 1849.

Work At Parexel International?

Share Your Experience

Parexel International vs competitors

Company	Founding Date	Zippia Score	Headquarters	# of Locations	Revenue	Employees
P Parexel International	1983	4.5	Waltham, MA	9	$2.4B	18,900
F Firma Clinical Research	2017	3.9	Chicago, IL	1	$2.6M	119
C Criterium	1991	4.0	Saratoga Springs, NY	1	$9.3M	50
G Globin Solutions	2017	3.3	Pittsburgh, PA	1	$39,000	1
E ExecuPharm	1995	4.7	King of Prussia, PA	1	$76.0M	750
C Charles River Labs	1947	4.3	Wilmington, MA	15	$4.0B	18,400
P Pharmaceutical Research Associates, Inc.	1981	4.6	Reston, VA	1	$30.0M	30
C Covance	1987	4.4	Princeton, NJ	25	$2.6B	50,000
P PRA Health Sciences	1976	4.3	Raleigh, NC	7	$3.2B	17,000
P Pharmaceutical Product Development	1985	4.1	Wilmington, NC	13	$65.0M	21,000
M Medpace	1992	4.5	Cincinnati, OH	3	$1.5B	2,800
V Vertex Pharmaceuticals	1989	4.6	Boston, MA	5	$8.9B	3,400
P Premier Research	1989	4.5	Philadelphia, PA	9	$54.0M	1,001
C Cytel	1987	4.5	Cambridge, MA	2	$49.9M	1,000
B Biorasi	2002	4.2	Hollywood, FL	2	$23.0M	750
N Novella	1998	4.2	Morrisville, NC	1	$9.2M	3,000
P Pfizer	1849	4.5	New York, NY	18	$100.3B	78,500
A Atlantic Research Group	2004	3.7	Charlottesville, VA	1	$3.6M	20

Rate Parexel International's competitiveness in the market.

Parexel International salaries vs Competitors

Among Parexel International competitors, employees at Cytel earn the most with an average yearly salary of $104,401.

Compare Parexel International Salaries VS Competitors

Company	Average Salary	Hourly Salary	Salary Score
P Parexel International	$91,480	$43.98	-
F Firma Clinical Research	$64,818	$31.16	-
C Criterium	$53,133	$25.54	-
G Globin Solutions	$44,823	$21.55	-
E ExecuPharm	$93,794	$45.09	-
C Charles River Labs	$45,905	$22.07	-

Compare Parexel International Job Title Salaries VS Competitors

Company	Highest Salary	Hourly Salary
P Parexel International	$98,693	$47.45
V Vertex Pharmaceuticals	$116,184	$55.86
P Pfizer	$102,647	$49.35
P Pharmaceutical Research Associates, Inc.	$97,202	$46.73
C Cytel	$95,816	$46.07
N Novella	$95,662	$45.99
C Charles River Labs	$95,547	$45.94
A Atlantic Research Group	$94,977	$45.66
P Pharmaceutical Product Development	$92,919	$44.67
P Premier Research	$92,511	$44.48
M Medpace	$92,394	$44.42
B Biorasi	$92,333	$44.39
F Firma Clinical Research	$92,148	$44.30
P PRA Health Sciences	$92,108	$44.28
G Globin Solutions	$91,905	$44.19
C Criterium	$90,118	$43.33
E ExecuPharm	$83,955	$40.36
C Covance	$82,546	$39.69

Do you work at Parexel International?

Is Parexel International able to compete effectively with similar companies?

Parexel International Jobs

Parexel International demographics vs competitors

Compare Gender At Parexel International Vs Competitors

Job Title	Male	Female
Medpace	33%	67%
PRA Health Sciences	37%	63%
Parexel International	40%	60%
Charles River Labs	42%	58%
Pfizer	55%	45%
Vertex Pharmaceuticals	56%	44%

Male

Female

100%

75%

50%

25%

Vertex Pharmaceuticals

Pfizer

Charles River Labs

Parexel International

PRA Health Sciences

Medpace

25%

50%

75%

100%

Compare Race At Parexel International Vs Competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity Score
P Parexel International	57%	13%	11%	15%	5%	9.8
C Charles River Labs	62%	15%	11%	9%	4%	9.7
M Medpace	66%	11%	8%	12%	3%	9.5
P Pfizer	55%	18%	10%	13%	4%	9.8
P PRA Health Sciences	63%	13%	10%	10%	3%	9.6
V Vertex Pharmaceuticals	56%	14%	7%	17%	6%	9.7

Parexel International REVENUE Vs Competitors

Parexel International revenue is $2.4B. Among it's competitors, the company with the highest revenue is Pfizer, $100.3B . The company with the lowest revenue is Globin Solutions, $39.0K.

Parexel International
Charles River Labs
Medpace
Pfizer

Parexel International And Similar Companies CEOs

CEOBio

James C. Foster

Charles River Labs

James Clifford Foster is the chairman and chief executive officer of Charles River Laboratories, Inc., an international company that works on the drug discovery and development process. Charles River Laboratories is the world's largest breeder of animals for use in laboratory experimentation.

August J. Troendle M.D.

Medpace

August Troendle is a Chairman/President/CEO/Founder at Medpace and is based in Ohio. He has worked as Board Member at Xenon Pharmaceuticals Inc. and Board Member at COHERUS BIOSCIENCES, INC.. August studied at University of Maryland.

Dr. Albert Bourla

Pfizer

Albert Bourla (Greek: Άλμπερτ Μπουρλά, born) is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

Colin Shannon

PRA Health Sciences

Colin Shannon is President, Chief Executive Officer (CEO) and Director for PRA. Since 2007, Mr. Shannon has served as President and Chief Operating Officer (COO) for PRA. Mr. Shannon has contributed significantly to the development of PRA's current mission and vision. As COO, he has been instrumental in driving PRA's decision-making processes and building a talented pool of clinical professionals.

Reshma Kewalramani M.d

Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Paul Kirchgraber

Covance

Paul Kirchgraber is a CEO at Covance.

Richard Staub

Novella

David Simmons

Pharmaceutical Product Development

Ludo Reynders

Premier Research

Jason J. Rose

Globin Solutions

Dr. Rose obtained his B.S.E. in Biomedical Engineering at the University of Michigan in 2006 and his M.D. from Wayne State University School of Medicine in 2010. He went on to Duke University Medical Center in North Carolina for his Internal Medicine Residency and the University of Pittsburgh for Pulmonary & Critical Care Medicine Fellowship. He obtained his MBA from Carnegie Mellon University’s Tepper School of Business in 2017 in a novel Biomedical Entrepreneurship Track. He is currently an Assistant Professor of Medicine at the University of Pittsburgh. He is part of the scientific team that developed Globin Solution’s lead compound, recombinant neuroglobin. His academic research work focuses on understanding the molecular mechanisms of CO poisoning and the effects of carbon monoxide poisoning on patients. He continues to serve as an attending physician in the intensive care unit. Dr Rose cofounded Globin Solutions, Inc., along with Drs. Gladwin and Tejero in 2017.